Tech Journal Mauritania: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal Mauritania.

Press releases published on September 8, 2026

an hour ago

Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

Indeterminate GlobeNewswire

an hour ago

Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

an hour ago

BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer

Indeterminate GlobeNewswire

an hour ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

an hour ago

Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer

Indeterminate GlobeNewswire

an hour ago

BrainChild Bio Closes $116 Million Series A Financing

Indeterminate GlobeNewswire

an hour ago

Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis

Indeterminate GlobeNewswire

an hour ago

NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director

Indeterminate GlobeNewswire

an hour ago

Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC

Indeterminate GlobeNewswire

an hour ago

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

Indeterminate GlobeNewswire

an hour ago

Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program

Indeterminate GlobeNewswire

an hour ago

DraftKings Extends Agreement with IC360 to Enhance Integrity Monitoring and Combat Athlete Harassment Across Sportsbook and Prediction Market Platforms

Indeterminate GlobeNewswire

an hour ago

Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire

an hour ago

Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026

Indeterminate GlobeNewswire

an hour ago

Rigetti Signs Definitive Agreement for $100M with U.S. Government to Accelerate R&D for Superconducting Quantum Computing

Indeterminate GlobeNewswire

an hour ago

NRx Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

an hour ago

OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

an hour ago

BrewDog Roars into Rugby with Five-Year Leicester Tigers Partnership, Bringing Punk Energy to Welford Road

Indeterminate GlobeNewswire

an hour ago

Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks

Indeterminate GlobeNewswire

2 hours ago

UK’s MHRA Accepts Biosplice’s Application for Lorecivivint (LOR) in Knee Osteoarthritis and Begins Assessment

Indeterminate GlobeNewswire